Jiangsu Hengrui Medicine
600276.SS
#422
Rank
ยฃ34.66 B
Marketcap
ยฃ5.43
Share price
0.37%
Change (1 day)
9.38%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07047. In 2022 the company made an earnings per share (EPS) of ยฃ0.07027 a decrease over its 2021 EPS that were of ยฃ0.08476.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075467.38%
2022ยฃ0.07027-17.1%
2021ยฃ0.08476-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0932525.58%
2018ยฃ0.0742527.55%
2017ยฃ0.0582221.64%
2016ยฃ0.0478613.57%
2015ยฃ0.0421439.86%
2014ยฃ0.0301321.33%
2013ยฃ0.0248317.7%
2012ยฃ0.0211025.56%
2011ยฃ0.0168026.22%
2010ยฃ0.0133110.3%
2009ยฃ0.0120757.92%
2008ยฃ0.00764311.06%
2007ยฃ0.00688285.81%
2006ยฃ0.00370387.94%
2005ยฃ0.00197133.97%
2004ยฃ0.00147129.78%
2003ยฃ0.00113319.78%
2002ยฃ0.0009461